scorecardresearch
Add as a preferred source on Google
Friday, March 13, 2026
TopicDengue

Topic: Dengue

India’s first dengue vaccine has been in the making for 17 yrs. DengiAll has the world excited

At the Panacea Biotec office, conversations around DengiAll are cloaked with an air of eagerness. With the human trials enrollment ending with over 10,000 participants, the company is waiting for approval.

How Serum Institute, DNDi tie-up for affordable antibody will bolster global fight against dengue

There is no specific medicine for dengue yet. If ongoing Phase III trials yield positive results, an effective, affordable & specific antiviral would be available, 'ultimately saving more lives'. 

Dengue fever outbreak grips the world. 5 ways to stop it

Over four billion people are currently at risk from mosquito-borne infections, including dengue, Zika, and chikungunya. It's estimated to rise to five billion by 2050.

India may soon get 1st dengue vaccine, but wait for jab effective against all 4 strains could be longer

With govt's local clinical trials waiver for certain drugs and vaccines, Japanese firm Takeda may soon launch QDenga, which will be a boost for India’s fight against dengue.

India sees alarming rise in dengue cases even before peak season, steady increase over past 4 years

Most number of cases in southern states, Maharashtra. Experts stress need for policy & community action, say global warming may have contributed to proliferation of source mosquitoes.

Covid antibodies making dengue more severe, suggests study by govt-run institute

This preprint study is 1st to demonstrate anti-SARS-CoV-2 antibodies can cross-react with dengue virus serotype and enhance its infection through antibody-dependent enhancement.

Japan firm Takeda’s dengue vaccine gets WHO panel backing, but no nod yet for phase 3 trials in India

Takeda's QDENGA, designed to protect against all 4 dengue virus serotypes, has been recommended by Strategic Advisory Group of Experts on Immunization for use in endemic countries.

Top Reasons Why Dengue Cases Are Getting More Severe

Dengue fever, caused by the Aedes mosquito, has long been a concern in tropical and subtropical regions, including parts of Asia, Latin America, and the Caribbean.

Vaccine manufacturer Indian Immunologicals Ltd to launch dengue vaccine by January 2026

According to NCDC, there was a 333% surge in dengue cases from 2020 to 2021 and a 21% rise in number of cases between 2021 and 2022.

US FDA takes new dengue vaccine by Japanese firm Takeda for priority review

Takeda has carried out phase 3 trials of the vaccine candidate and found it to be 80.2% effective in preventing symptomatic dengue cases after a year of vaccination.

On Camera

Period pain is real. Blanket menstrual leave policy isn’t a fix

The Supreme Court is right to point out the 'mindset of employers', who, because of this policy, may deduce that 'women are inferior.'

A war in the Gulf, a crisis in Gujarat’s Morbi: India’s ceramics capital counts the cost

Morbi makes 80-90% of India’s ceramic exports. The West Asia conflict has cut its propane supply, shutting 200 factories and threatening 400 more—along with 9 lakh livelihoods.

Supreme Leader Mojtaba, the man Iran must keep alive & the secret force ‘tasked with it’—all about NOPO

The Nirouyeh Vijeh Pasdaran Velayat, or NOPO, was the only force Ali Khamenei trusted.It was founded in 1991 and is more feared than the Revolutionary Guards.

Trump brings the Age of Humiliation for friends. Modi needs stoicism abroad, humility at home

Trump has ushered in the age of humiliation. His method is to push around America’s friends rudely and publicly. He knows none of them can afford to fight back.